{
    "sec_cik": "0000872589",
    "sec_company_name": "REGENERON PHARMACEUTICALS, INC. (Filer)",
    "document_type": "10K",
    "sec_form_header": "Form 10-K",
    "sec_period_of_report": "20201231",
    "sec_filing_date": "20210208",
    "sec_changed_date": "20210208",
    "sec_accepted_date": "20210208091300",
    "sec_index_url": "https://www.sec.gov//Archives/edgar/data/872589/000180422021000008/0001804220-21-000008-index.htm",
    "sec_url": "https://www.sec.gov//Archives/edgar/data/872589/000180422021000008/0001804220-21-000008.txt",
    "metadata_file_name": "C:\Users\aaron\OneDrive\Desktop\homework\finance2\SEC-EDGAR-text\output_files_examples\batch_0012\003\REGN_0000872589_10K_20201231_Item7_metadata.json",
    "original_file_name": "",
    "original_file_size": "3775077 chars",
    "document_group": "10-K",
    "section_name": "Item7",
    "section_n_characters": 52646,
    "endpoints": [
        "ITEM 7. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS",
        "ITEM 7A. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK"
    ],
    "extraction_method": "xbrl",
    "warnings": [],
    "company_description": "REGN",
    "output_file": "C:\Users\aaron\OneDrive\Desktop\homework\finance2\SEC-EDGAR-text\output_files_examples\batch_0012\003\REGN_0000872589_10K_20201231_Item7_excerpt.txt",
    "time_elapsed": 0.7,
    "batch_number": 12,
    "batch_signature": "",
    "batch_start_time": "2023-04-27 16:50:45.547561",
    "batch_machine_id": "DESKTOP-BTCJU5K",
    "section_end_time": "2023-04-27 17:07:18.022630"
}